| Autor: |
Bolouri H; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. hbolouri@fhcrc.org., Farrar JE; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences and Arkansas Children's Research Institute, Little Rock, Arkansas, USA., Triche T Jr; Jane Anne Nohl Division of Hematology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.; Van Andel Research Institute, Grand Rapids, Michigan, USA., Ries RE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Lim EL; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.; Children's Oncology Group, Monrovia, California, USA., Ma Y; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Moore R; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Marra MA; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Zhang J; Division of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Ma X; Division of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Liu Y; Division of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Liu Y; Division of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Auvil JMG; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA., Davidsen TM; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA., Gesuwan P; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA., Hermida LC; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA., Salhia B; Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Capone S; Jane Anne Nohl Division of Hematology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Ramsingh G; Jane Anne Nohl Division of Hematology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Zwaan CM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Noort S; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Piccolo SR; Department of Biology, Brigham Young University, Provo, Utah, USA.; Department of Biomedical Informatics, University of Utah, Salt Lake City, Utah, USA., Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, Delaware, USA., Gamis AS; Division of Hematology, Oncology and Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA., Smith MA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA., Gerhard DS; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA., Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. smeshinc@fhcrc.org. |
Full text from SpringerLink